“Detection, risk factors, and functional consequences of cerebral microinfarcts” has been published in The Lancet Neurology. This work was supported in part by JPND through the HARNESS project, selected in the 2016 Brain Imaging Working Groups call.
Category Archives: JPND Publications
“New insights into the genetic etiology of Alzheimer’s disease and related dementias” has been published in the Journal of Nature Genetics. This work was supported in part by JPND through the EADB project.
“Contribution to Alzheimer’s disease risk of rare variants in TREM2, SORL1 and ABCA7 in 1,779 cases and 1,273 controls” will be published in the journal Neurobiology of Aging. This work was supported in part by JPND through the PERADES project, selected in the 2012 Risk Factors call.
“Physico-Pathologic Mechanisms Involved in Neurodegeneration: Misfolded Protein-Plasma Membrane Interactions” has been published in the journal Neuron. This work was supported in part by JPND through the NeuTARGETS project, selected in the 2013 Cross-Disease Analysis call, and through the SYNACTION project, selected in the 2015 JPco-fuND call.
“Prospective clinical and DaT-SPECT imaging in premotor LRRK2 G2019S-associated Parkinson disease” has been published in the journal Neurology. This work was supported in part by JPND through the DEMTEST project, selected in the 2011 Biomarkers call.
“Extracellular vesicles: Novel promising delivery systems for therapy of brain diseases” has been published in the Journal of Controlled Release. This work was supported in part by JPND through the ModelPolyQ project, selected in the 2015 JPco-fuND call.
“Does participation in the Meeting Centre Support Programme change the stigma experienced by people with dementia?” has been published in the journal European Psychiatry. This work was supported by JPND through the MEETINGDEM project, selected in the 2012 Healthcare Evaluation call.
“Neurofilament markers for ALS correlate with extent of upper and lower motor neuron disease” has been published in the journal Neurology. This work was supported in part by JPND through the STRENGTH and RiMod-FTD projects, selected in the 2012 Risk Factors call.
“Decreased plasma β-amyloid in the Alzheimer’s disease APP A673T variant carriers” has been published in the journal Annals of Neurology. This work was supported in part by JPND through the EADB project, selected in the 2015 JPco-fuND call.
“Epigenetic mechanisms during ageing and neurogenesis as novel therapeutic avenues in human brain disorders” has been published in the journal Clinical Epigenetics. This work was supported in part by JPND through the EPI-AD project, selected in the 2015 JPco-fuND call.
“Influence of arterial hypertension, type 2 diabetes and cardiovascular risk factors on ALS outcome: a population-based study“ has been published in the journal Amyotrophic Lateral Sclerosis and Frontotemporal Degeneration. This work was supported in part by JPND through the STRENGTH project, selected in the 2012 Risk Factors call, and the SOPHIA project, selected in the 2011 Biomarkers call.